High-Risk HPV May Be Associated With CVD in Korean Women
High-risk human papillomavirus infection may be associated with the risk for cardiovascular disease in Korean women.
Cancer
Decline Observed in HPV Type 16/18 Cervical Precancers in US
Decline observed in HPV type 16/18 cervical precancers.
44.4 Million Estimated to Be Diagnosed With Cervical Cancer by 2069
In the absence of further intervention, in the next 50 years, an estimated 44.4 million women will be diagnosed with cervical cancer globally.
Cervical Lesion Treatment Failure Prevalent in Women With HIV
Premalignant cervical lesion treatment failure is more prevalent in women with HIV than women without HIV.
Many New Cancer Patients Unaware of Their Hepatitis Status
Large proportion of participants with newly diagnosed cancer learned of infection through study.
Educational Intervention Improves HPV Vaccination
Educational interventions delivered in a clinical setting may improve vaccination behaviors.
HIV & Cancer Risk: Expert Interview
Although rates of AIDS-defining malignancies have declined in recent decades, cancer remains a leading cause of mortality in people living with HIV.
Cisplatin Superior to Cetuximab for HPV+ Oropharyngeal Cancer
For treatment of HPV positive low-risk oropharyngeal cancer, cetuximab shows no benefit compared with the standard cisplatin regimen in terms of reduced toxicity and results in worse tumor control.
Increased Risk for First and Second Primary Cancers in Patients With HIV/AIDS
Increased cancer prevention, screening, and treatment are needed for people living with HIV both before and after an initial cancer diagnosis.
Hispanics With HIV Face Higher Risk for HPV-Related Cancer
But five-year survival was above 50 percent among HIV-infected Hispanics across HPV-related cancer types.
Next post in HIV/AIDS
